Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China flag China · Delayed Price · Currency is CNY
21.92
+0.04 (0.18%)
May 23, 2025, 2:45 PM CST

Nanjing Vazyme Biotech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-21.4-18.09-70.96594.25678.29821.73
Upgrade
Depreciation & Amortization
138.01138.01157.38122.155.2813.73
Upgrade
Other Amortization
75.3175.3178.2694.8327.929.71
Upgrade
Loss (Gain) From Sale of Assets
2.12.1-5.670.22-0.010.05
Upgrade
Asset Writedown & Restructuring Costs
1.81.81.73236.852.351.71
Upgrade
Loss (Gain) From Sale of Investments
-59.9-59.9-50.92-88.02-29.81-14.94
Upgrade
Provision & Write-off of Bad Debts
20.2620.26-7.2791.6812.0810.46
Upgrade
Other Operating Activities
86.8757.09165.4333.0746.6154.99
Upgrade
Change in Accounts Receivable
-188.25-188.25534.67-682.89-133.2-164.36
Upgrade
Change in Inventory
-39.04-39.04-124.37-403.82-148.94-128.2
Upgrade
Change in Accounts Payable
-13-13-511.13464.58113.78169.23
Upgrade
Change in Other Net Operating Assets
53.5653.5625.287.377.4710.62
Upgrade
Operating Cash Flow
16.8-9.68152.99735.17616.8803.55
Upgrade
Operating Cash Flow Growth
-90.70%--79.19%19.19%-23.24%5185.70%
Upgrade
Capital Expenditures
-58.69-74.9-232.9-962.86-261.96-152.54
Upgrade
Sale of Property, Plant & Equipment
1.342.4713.4815.592.730.17
Upgrade
Cash Acquisitions
----117.93--
Upgrade
Investment in Securities
-479.1395.03-726.6551.07-1,195-794.95
Upgrade
Other Investing Activities
60.1352.645.4261.726.1514.29
Upgrade
Investing Cash Flow
-476.31375.21-900.65-952.44-1,428-933.03
Upgrade
Short-Term Debt Issued
-1,1051,461372-29.51
Upgrade
Long-Term Debt Issued
-0.020.56---
Upgrade
Total Debt Issued
939.021,1051,462372-29.51
Upgrade
Short-Term Debt Repaid
--1,723-638.79-156.41-39.56-64
Upgrade
Total Debt Repaid
-945.77-1,723-638.79-156.41-39.56-64
Upgrade
Net Debt Issued (Repaid)
-6.75-618.8822.77215.59-39.56-34.49
Upgrade
Issuance of Common Stock
38.538.5--2,129300
Upgrade
Repurchase of Common Stock
-104.4-104.4-20.01---
Upgrade
Common Dividends Paid
-77.06-80.36-533.33-132.24-4.45-1.45
Upgrade
Other Financing Activities
-3.05-21.21-19.63-4.3-15.2-2.86
Upgrade
Financing Cash Flow
-152.75-786.27249.879.052,070261.2
Upgrade
Foreign Exchange Rate Adjustments
-0.68-4.241.465.04-2.32-3.9
Upgrade
Net Cash Flow
-612.94-424.98-496.4-133.181,256127.83
Upgrade
Free Cash Flow
-41.89-84.58-79.91-227.69354.84651.01
Upgrade
Free Cash Flow Growth
-----45.49%-
Upgrade
Free Cash Flow Margin
-3.08%-6.14%-6.21%-6.38%18.99%41.61%
Upgrade
Free Cash Flow Per Share
-0.13-0.23-0.20-0.570.981.83
Upgrade
Cash Income Tax Paid
57.9861.1499.76146.72175.67152.17
Upgrade
Levered Free Cash Flow
-49.24-105.83-102.16-451.34181.59403.29
Upgrade
Unlevered Free Cash Flow
-33.44-88.79-80.25-443.54184403.94
Upgrade
Change in Net Working Capital
162.45210.25-67.65236.38100.974.41
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.